Countries: Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, Uzbekistan
Services: Technical Assistance, Assessment, Applied Technology, Training
Technical Expertise: Health Supply Chain Management, Infectious Diseases
Tuberculosis (TB) has emerged as a major public health threat. With infection rates increasing steadily, the Central Asian Republics (CAR) have the highest rates of all former Soviet republics. Thus, the demand for TB drugs has increased and the governments of the countries in that region have scaled-up efforts aimed at controlling TB. Problems such as poor access to high-quality TB drugs and poor availability and access to first-line TB drugs have resulted in treatment interruptions, and the creation of an environment for the development of drug resistance. Although drug availability has been linked to lack of financial resources, the lack of rational systems and drug management knowledge and skills among MOH staff involved in administering TB control programs have also contributed to the lack of availability.
Beginning in 1997, USAID began funding projects in the Central Asian Republics to address the increase in TB prevalence.
The five-year Central Asian TB Expansion and Improvement Project, funded by USAID, addressed issues having to do with limited access to high-quality TB drugs, lack of rational systems and drug management knowledge, and skills among Ministry of Health staff when administering TB control programs. Under this project, JSI, in a subcontract to Project HOPE, worked to improve TB drug treatment and strengthen commodity security in health facilities.